AstraZeneca

‘I’ve got a CO2 budget for travel: AstraZeneca IR head talks corporate access in the sustainability era

Article

Corporate access

‘I’ve got a CO2 budget for travel: AstraZeneca IR head talks corporate access in the sustainability era

Nov 01, 2023

By Garnet Roach

Gervais Williams on why UK equities will outperform their US rivals: The Ticker 142

Article

Investor perspectives

Learning on the job with AstraZeneca's head of IR and Gervais Williams on why UK equities will outperform US: The Ticker 142

Sep 20, 2023

By Staff Writers

How AstraZeneca reports its ESG performance

Article

How AstraZeneca reports its ESG performance

May 30, 2023

Red-carpet interview: AstraZeneca’s Andy Barnett on a ‘remarkable year’

Article

Red-carpet interview: AstraZeneca’s Andy Barnett on a ‘remarkable year’

Jul 26, 2022

Banco Santander, LVMH, Nestlé and Stellantis among nominees for IR Magazine Awards – Europe 2022

Article

Banco Santander, LVMH, Nestlé and Stellantis among nominees for IR Magazine Awards – Europe 2022

May 30, 2022

‘The pandemic has changed IR’: Thomas Kudsk Larsen on his move from AstraZeneca to small cap Sobi

Article

‘The pandemic has changed IR’: Thomas Kudsk Larsen on his move from AstraZeneca to small cap Sobi

Dec 02, 2021

By Garnet Roach

AstraZeneca, BBVA and Polymetal out in front as short lists released for IR Magazine Awards – Europe 2021

Article

AstraZeneca, BBVA and Polymetal out in front as short lists released for IR Magazine Awards – Europe 2021

May 27, 2021

By Staff Writers

The week in investor relations: Man Utd and Juventus investor criticism, human capital focus at the SEC and bumper pay for AstraZeneca CEO

Article

The week in investor relations: Man Utd and Juventus investor criticism, human capital focus at the SEC and bumper pay for AstraZeneca CEO

May 14, 2021

By Garnet Roach

Adding video to the spread: AstraZenenca on enhancing the webcast

Article

Adding video to the spread: AstraZenenca on enhancing the webcast

Jan 22, 2019

By Garnet Roach

30 IR stars in 30 days: Thomas Kudsk Larsen of AstraZeneca

Article

Corporate access

30 IR stars in 30 days: Thomas Kudsk Larsen of AstraZeneca

Dec 14, 2018

By Garnet Roach

Subscribe to AstraZeneca